Identification of a Novel Intestinal First Pass Metabolic Pathway: NQO1 Mediated Quinone Reduction and Subsequent Glucuronidation

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|8|2|137-149

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.8, Iss.2, 2007-02, pp. : 137-149

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quinone reductase (NQO1), a sensitive redox indicator, is increased in Alzheimer's disease

By Raina A.K.   Templeton D.J.   deak J.C.   Perry G.   Smith M.A.  

Redox Report, Vol. 4, Iss. 1-2, 1999-02 ,pp. : 23-27

Maney Publishing

Access to resources Recommend Favorite

Ranitidine Increases Bioavailability of Acetaminophen by Inhibiting First-Pass Glucuronidation in Man

By Itoh H.   Nagano T.   Hayashi T.   Takeyama M.  

Pharmacy and Pharmacology Communications, Vol. 6, Iss. 11, 2000-11 ,pp. : 495-500

Pharmaceutical Press

Access to resources Recommend Favorite

Biological and Clinical Significance of Polymorphisms in NAD(P)H: Quinone Oxidoreductase 1 (NQO1)

By  

Current Pharmacogenomics, Vol. 2, Iss. 1, 2004-03 ,pp. : 75-82

Bentham Science Publishers

Access to resources Recommend Favorite

Prediction of Intestinal First-Pass Drug Metabolism

By  

Current Drug Metabolism, Vol. 8, Iss. 7, 2007-10 ,pp. : 676-684

Bentham Science Publishers

Access to resources Recommend Favorite

Intestinal Lymphatic Transport Enhances the Post-Prandial Oral Bioavailability of a Novel Cannabinoid Receptor Agonist Via Avoidance of First-Pass Metabolism

By Trevaskis Natalie   Shackleford David   Charman William   Edwards Glenn   Gardin Anne   Appel-Dingemanse Silke   Kretz Olivier   Galli Bruno   Porter Christopher  

Pharmaceutical Research, Vol. 26, Iss. 6, 2009-06 ,pp. : 1486-1495

Springer Publishing Company

Access to resources Recommend Favorite